A detailed history of Temasek Holdings (Private) LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 233,498 shares of ABBV stock, worth $42 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
233,498
Holding current value
$42 Million
% of portfolio
0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $38.3 Million - $46.5 Million
233,498 New
233,498 $46.1 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $12.9 Million - $15 Million
83,174 Added 76.15%
192,405 $33 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $11.7 Million - $13.4 Million
73,466 Added 205.41%
109,231 $19.9 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $2.51 Million - $2.83 Million
18,239 Added 104.07%
35,765 $5.54 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $2.34 Million - $2.71 Million
17,526 New
17,526 $2.61 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.